Evidence map›Paper›PMID 37238982›Full record

ArticleBiomedicines2023

A Pilot Study on Oxidative Stress during the Recovery Phase in Critical COVID-19 Patients in a Rehabilitation Facility: Potential Utility of the PAOT

Joël Pincemail, Anne-Françoise Rousseau, Jean-François Kaux, Jean-Paul Cheramy-Bien, Christine Bruyère, Jeanine Prick, David Stern, Mouna-Messaouda Kaci, Benoît Maertens De Noordhout, Adelin Albert and 6 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Joël PincemailClinical Chemistry, University Hospital of Liège, Sart Tilman, 4000 Liège, Belgium.
Anne-Françoise RousseauIntensive Care Department, University Hospital of Liège, Sart Tilman, 4000 Liège, Belgium.ORCID 0000-0002-4157-6570
Jean-François KauxPhysical Medicine Rehabilitation and Sports Traumatology Department Sports, University Hospital of Liège, Sart Tilman, 4000 Liège, Belgium.ORCID 0000-0003-1939-3652
Jean-Paul Cheramy-BienDepartment of Cardiovascular Surgery, University Hospital of Liège, Sart Tilman, 4000 Liège, Belgium.ORCID 0000-0003-1846-1326
Christine BruyèrePhysical Medicine Rehabilitation and Sports Traumatology Department Sports, University Hospital of Liège, Sart Tilman, 4000 Liège, Belgium.
Jeanine PrickPhysical Medicine Rehabilitation and Sports Traumatology Department Sports, University Hospital of Liège, Sart Tilman, 4000 Liège, Belgium.
David SternVeterinary Medicine Faculty, FARAH, University of Liège, Sart Tilman, 4000 Liège, Belgium.
Mouna-Messaouda KaciResearch Department, Institut Européen des Antioxydants (IEA), Oxystress Technologies PAOTScan, 54500 Vandœuvre-lès-Nancy, France.
Benoît Maertens De NoordhoutPhysical Medicine Rehabilitation and Sports Traumatology Department Sports, University Hospital of Liège, Sart Tilman, 4000 Liège, Belgium.
Adelin AlbertBiostatistics Department, University Hospital of Liège, Sart Tilman, 4000 Liège, Belgium.
Céline EubelenPhysical Medicine Rehabilitation and Sports Traumatology Department Sports, University Hospital of Liège, Sart Tilman, 4000 Liège, Belgium.
Caroline Le GoffClinical Chemistry, University Hospital of Liège, Sart Tilman, 4000 Liège, Belgium.
Benoît MissetIntensive Care Department, University Hospital of Liège, Sart Tilman, 4000 Liège, Belgium.
Etienne CavalierClinical Chemistry, University Hospital of Liège, Sart Tilman, 4000 Liège, Belgium.
Corinne CharlierToxicology Department, University Hospital of Liège, Sart Tilman, 4000 Liège, Belgium.
Smail MezianeResearch Department, Institut Européen des Antioxydants (IEA), Oxystress Technologies PAOTScan, 54500 Vandœuvre-lès-Nancy, France.
University of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOxidative stress (OS) could cause various COVID-19 complications. Recently, we have developed the Pouvoir AntiOxydant Total (PAOT®) technology for reflecting the total antioxidant capacity (TAC) of biological samples. We aimed to investigate systemic oxidative stress status (OSS) and to evaluate the utility of PAOT® for assessing TAC during the recovery phase in critical COVID-19 patients in a rehabilitation facility. MATERIALS AND

methodsIn a total of 12 critical COVID-19 patients in rehabilitation, 19 plasma OSS biomarkers were measured: antioxidants, TAC, trace elements, oxidative damage to lipids, and inflammatory biomarkers. TAC level was measured in plasma, saliva, skin, and urine, using PAOT and expressed as PAOT-Plasma, -Saliva, -Skin, and -Urine scores, respectively. Plasma OSS biomarker levels were compared with levels from previous studies on hospitalized COVID-19 patients and with the reference population. Correlations between four PAOT scores and plasma OSS biomarker levels were analyzed.

resultsDuring the recovery phase, plasma levels in antioxidants (γ-tocopherol, β-carotene, total glutathione, vitamin C and thiol proteins) were significantly lower than reference intervals, whereas total hydroperoxides and myeloperoxidase (a marker of inflammation) were significantly higher. Copper negatively correlated with total hydroperoxides (r = 0.95,

Indexed as

blood oxidative stress statuspatient rehabilitationpost-COVID-19 pneumonia

Identifiers

PMID37238982
PMCPMC10216138
OpenAlexW4367313568

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.